Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |